Comprehensive immune response analysis for vaccine and therapeutic research
Our Immunology services provide advanced platforms and expertise to analyse immune responses critical for vaccine development, infectious disease research, and cardiometabolic programs. Leveraging cutting-edge technologies, we deliver reproducible, regulatory-compliant data.
- ELISA for protein and antibody quantification
- ELISpot for antigen-specific T cell analysis
- Multiplex cytokine and chemokine profiling
- Neutralization assays for binding and functional antibodies
- PBMC isolation and immune cell characterisation
- Immune Repertoire Sequencing
Vaccine development and immunogenicity studies
Infectious disease research
Cardiometabolic biomarker analysis
Benefits
- High-throughput, automated immunology workflows
- Regulatory-compliant processes
- Expert interpretation and reporting
Related Resources
Explore our blogs and resources on Virus & Bacteria Production & Characterisation for Human Challenge Trials, covering GMP manufacturing and scientific characterisation approaches used to develop safe, infectious challenge agents for high-fidelity clinical studies.
CIR Accreditation: Strengthening hVIVO’s Integrated Early‑Phase Engine for French Sponsors
Automation Is Transforming Lab Productivity - and Unlocking New Scientific Possibilities
Empowering Next‑Gen Infectious Disease & Vaccine Development
Enhancing Our Full-Service Offering: hVIVO’s New Bacteriology Lab
Advantages to Centralised Laboratory Services
Assays as Architecture: Building Blocks for Translational Research
Why NGS Is the Missing Link in Early‑Phase Infectious Disease Research
Controlled Human Infection Model's (CHIM) in your backpack: how Human Challenge Trials support regulatory approval of travel vaccines
Fact Sheet: De-Risking Sample Management
